C-terminal cysteine residues determine the IgE binding of Aspergillus fumigatus allergen asp f 2

被引:17
作者
Banerjee, B
Kurup, VP
Greenberger, PA
Kelly, KJ
Fink, JN
机构
[1] Zablocki Vet Affairs Med Ctr, Res Serv 151 I, Milwaukee, WI 53295 USA
[2] Med Coll Wisconsin, Dept Pediat, Div Allergy Immunol, Milwaukee, WI 53226 USA
[3] Northwestern Univ, Sch Med, Chicago, IL 60611 USA
关键词
D O I
10.4049/jimmunol.169.9.5137
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The knowledge of the structure function relationship of the allergen is essential to design allergenic variants with reduced IgE binding capacity but intact T cell reactivity. Asp f 2 is a major allergen from the fungus Aspergillus fumigatus and > 90% of A. fumigatus-sensitized individuals displayed IgE binding to Asp f 2. In the present study, we evaluated the involvement of C-terminal cysteine residues in IgE binding conformation of Asp f 2. The deletion mutants were constructed by adding three C-terminal cysteines of the native Asp f 2 one at a time to the non-IgE binding Asp f 2 (68-203). The point mutants of Asp f 2 (68-268) with C204A and C257A substitutions were constructed to study the role of-C-terminal cysteines in IgE binding. Immunological evaluation of reduced and alkylated Asp f 2 and its mutants were conducted to determine the contribution of free sulfhydryl groups as well as the disulfide bonds in allergen Ab interaction. Four-fold increase in IgE Ab binding of Asp f 2 (68-267) compared with Asp f 2 (68-266) and comp fete loss in IgE binding of C204A mutant of Asp f 2.(68-268) indicate the involvement of C-204 and C-267 in IgE binding conformation of Asp f 2. A significant reduction in IgE binding of wild and mutated Asp f 2 after reduction and alkylation emphasizes the importance of cysteine disulfide bonds in epitope Ab interaction. The hypoallergenic variants may be explored further to develop safe immumotherapeutic strategy for allergic disorders.
引用
收藏
页码:5137 / 5144
页数:8
相关论文
共 28 条
[1]   Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis [J].
Banerjee, B ;
Greenberger, PA ;
Fink, JN ;
Kurup, VP .
INFECTION AND IMMUNITY, 1998, 66 (11) :5175-5182
[2]   Molecular cloning and expression of a recombinant Aspergillus fumigatus protein Asp f II with significant immunoglobulin E reactivity in allergic bronchopulmonary aspergillosis [J].
Banerjee, B ;
Kurup, VP ;
Phadnis, S ;
Greenberger, PA ;
Fink, JN .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 127 (03) :253-262
[3]   Purification of a major allergen, Asp f 2 binding to IgE in allergic bronchopulmonary aspergillosis, from culture filtrate of Aspergillus fumigatus [J].
Banerjee, B ;
Kurup, VP ;
Greenberger, PA ;
Hoffman, DR ;
Nair, DS ;
Fink, JN .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (06) :821-827
[4]   Conformational and linear B-cell epitopes of Asp f 2, a major allergen of Aspergillus fumigatus, bind differently to immunoglobulin E antibody in the sera of allergic bronchopulmonary aspergillosis patients [J].
Banerjee, B ;
Greenberger, PA ;
Fink, JN ;
Kurup, VP .
INFECTION AND IMMUNITY, 1999, 67 (05) :2284-2291
[5]  
BECKER WM, 1994, IMMUN INFEKT, V22, P82
[6]  
Colombo P, 1998, J IMMUNOL, V160, P2780
[7]  
Friguet B., 1997, PROTEIN STRUCTURE PR, P323
[8]  
HOLECKER M, 1997, PROTEIN STRUCTURE, P151
[9]  
Kauppinen J, 1999, CLIN EXP ALLERGY, V29, P989
[10]   Respiratory fungal allergy [J].
Kurup, VP ;
Shen, HD ;
Banerjee, B .
MICROBES AND INFECTION, 2000, 2 (09) :1101-1110